Skip to Main Content

Author Details

Evangelos Pazarentzos
University of California san francisco
2011
20
15
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35419474Cell demise inhibited: Unexpected liaisons between mitochondria and Iκοα.Mol Cell Oncol2022
28287179Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution.Sci Rep2017
25982275Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3Cβ(D1067V) kinase domain mutation.Oncogene2016
27431938The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.Brain Res2016
24769897The anticancer gene ORCTL3 targets stearoyl-CoA desaturase-1 for tumour-specific apoptosis.Oncogene2015
26301689RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.Nat Med2015
25843712NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.Cell Rep2015
25873175AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.Cancer Cell2015
25703329Adaptive stress signaling in targeted cancer therapy resistance.Oncogene2015
25665005The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.Nat Genet2015
25578148Stefan Grimm, 1963-2014, a tragic loss for the scientific community.Cell Death Differ2015
24522192CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex.J Cell Sci2014
25361605Iκοα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention.EMBO J2014
25001541Anticancer gene transfer for cancer gene therapy.Adv Exp Med Biol2014
24948011Mitochondrial Ca(2+) influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction.Cell Death Differ2014
23799534Dose-dependent neuroprotection of VEGF⿁⿿⿿ in Huntington's disease striatum.Mol Ther2013
22179575De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF.Cell Death Differ2012
22659130De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1.Biochim Biophys Acta2012
20706275Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction.Cell Death Differ2011
21183955Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction.EMBO J2011
  • 1 - 20 of 20

Recommended Authors

Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2015
Number of shared co-authors 0
Daniel D'Andrea
Nottingham Trent University
Career Start Year 2010
Number of shared co-authors 0
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2009
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Isabelle Martins
Universite de Paris, Sorbonne Universite, Inserm U8, Institut Universitaire de France
Career Start Year 2007
Number of shared co-authors 0
In??s A Barbosa
Research Institute of Molecular Pathology
Career Start Year 2007
Number of shared co-authors 0
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 2
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Barak Rotblat
Ben-Gurion University of the Negev
Career Start Year 2002
Number of shared co-authors 0
Andrea Viale
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Darren L Roberts
The University of Manchester
Career Start Year 2001
Number of shared co-authors 0
Vivek Shukla
Chalmers University of Technology
Career Start Year 2000
Number of shared co-authors 0
Evripidis Gavathiotis
Albert Einstein College of Medicine
Career Start Year 2000
Number of shared co-authors 1
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 0
Chandra C Ghosh
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 5
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 3
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 0
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 2
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 0
David J McConkey
Johns Hopkins School of Medicine
Career Start Year 1986
Number of shared co-authors 0
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 1
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 8

Collaborators

Trever G Bivona
University of California san francisco
Co-authored papers 7
Victor Olivas
University of California san francisco
Co-authored papers 5
Saurabh Asthana
University of California San Francisco
Co-authored papers 4
Luping Lin
Incyte Research Institute, Incyte Corporation
Co-authored papers 4
Collin M Blakely
University of California san francisco
Co-authored papers 3
Elton Chan
University of California san francisco
Co-authored papers 3
Matthew A Gubens
University of California san francisco
Co-authored papers 3
Gorjan Hrustanovic
University of California san francisco
Co-authored papers 3
Dana S Neel
Stanford University School of Medicine
Co-authored papers 3
Jenny Jiacheng Yan
Helen Diller Comprehensive Cancer Center, University of California san francisco
Co-authored papers 3
Eric A Collisson
University of California san francisco
Co-authored papers 2
Jose Miguel Sanchez
Co-authored papers 1
José Baselga
Co-authored papers 1
Sourav Bandyopadhyay
University of California San Francisco
Co-authored papers 1
Timothy R Fouts
Profectus BioSciences Inc.
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Manway Liu
Verily Life Sciences LLC
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Angela Tam
Co-authored papers 1
Jennifer A Wargo
Co-authored papers 1
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Irena Tan
Co-authored papers 1
Kathryn Bobb
Profectus BioSciences Inc.
Co-authored papers 1
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Co-authored papers 1
Jeffrey Meshulam
Co-authored papers 1
Billy W Newton
University of California San Francisco
Co-authored papers 1
Release 1.2